MediumCardiologyHeart failure with reduced ejection fractionau-amcau-racp
A 72-year-old man with ischaemic cardiomyopathy (left ventricular ejection fraction 30%) is clinically euvolaemic on examination. His current medications are ramipril, bisoprolol and frusemide. His potassium is 4.4 mmol/L and creatinine 100 µmol/L. According to heart failure guidelines, what additional disease-modifying medication class should be considered to improve prognosis?